M3-JIA: Making Mindfulness Matter for Children With JIA

Study acronym: M3-JIA
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 6 months later Dec 2025 → Jul 2027
See other at-risk trials from London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 2025 to Jul 2027 Show 6 more changesShow less
    • Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's to London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
    • Study completion pushed from Feb 2026 to Sep 2027
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised at 2 of 3 sites
    • Publications: details revised at 3 of 3 entries
  2. Minor Re-verified, no change to tracked fieldsv5
  3. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 3 of 3 sites
    v4
  4. Minor Trial status: Not Yet Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Aug 2024 to Sep 12, 2024
    • Secondary endpoints: details revised at 4 of 4 entries
    • Study sites revised (3)
    • Publications: 4 to 3
  5. Minor Secondary endpoints: details revised at 1 of 4 entriesv2
  6. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigator will evaluate the efficacy of M3©, an intervention for patients with JIA and their caregivers. Children with Juvenile arthritis and their parents will attend an 8 week online program called Making Mindfulness Matter (M3). This is a facilitator-led program that integrates knowledge and skills related to mindfulness, social-emotional learning, neuroscience, and positive psychology to promote coping and resiliency for children and families in context of the challenges of pediatric chronic disease. The child program is designed for children 4-12 years of age, with each lesson including a variety of concrete ways to teach children skills based on their age/developmental level.
Trial Details
NCT Number NCT06376149
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Brain Canada
Conditions
(from sponsor)
Juvenile Idiopathic Arthritis, Children, Mental Health, Mental Well-being
Related terms Arthritis, Juvenile, Psychological Well-Being
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov